ISPOR - PBI23 Cost Saving Opportunity for the Treatment of Psoriasis: The Use of Adalimumab Biosimilars

PBI23 Cost Saving Opportunity for the Treatment of Psoriasis: The Use of Adalimumab Biosimilars

Abstract

Authors

T. Weber M. Bodin G. Wildenburg M. Dorn F. Sasso G. Tirvengadum B. Olivares O. Mora Maltas S. Keady

Full Text Cite This Article

Back to Volume 23, Supplemental S2

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now